Extended ovarian transport for centralized tissue cryobanking: impact on primordial follicle integrity.
1/5 보강
[OBJECTIVE] To evaluate the impact of ovarian tissue transportation on human primordial follicle integrity before cortical tissue cryopreservation.
- 표본수 (n) 13
APA
Erden M, Celik S, et al. (2026). Extended ovarian transport for centralized tissue cryobanking: impact on primordial follicle integrity.. Fertility and sterility, 125(1), 118-126. https://doi.org/10.1016/j.fertnstert.2025.08.001
MLA
Erden M, et al.. "Extended ovarian transport for centralized tissue cryobanking: impact on primordial follicle integrity.." Fertility and sterility, vol. 125, no. 1, 2026, pp. 118-126.
PMID
40783168 ↗
Abstract 한글 요약
[OBJECTIVE] To evaluate the impact of ovarian tissue transportation on human primordial follicle integrity before cortical tissue cryopreservation.
[DESIGN] Translational research study.
[SUBJECTS] Whole ovaries (n = 13) or ovarian cortex (n = 3) from 16 individuals (10 deceased organ donors and 6 undergoing clinical ovarian tissue cryopreservation) were transported to our center in appropriate media for cryopreservation. In the clinical group indications were as follows: planned (elective, n = 3), high-grade serous ovarian cancer (n = 1), endometriosis (n = 1), and Hodgkin lymphoma (n = 1).
[EXPOSURE] Transport duration was calculated from cross-clamp time for organ donors, and from the time of oophorectomy or ovarian tissue excision for patients, until ovarian tissue cryopreservation.
[MAIN OUTCOME MEASURES] Antiactive caspase-3, γH2AX, and hypoxia-inducible factor 1-alpha immunostaining were performed to assess follicular and stromal cell apoptosis, oocyte deoxyribonucleic acid (DNA) damage, and tissue hypoxia. Follicle activation was assessed by primordial follicle growth initiation index, defined as the primary/primordial follicle ratio.
[RESULTS] Primordial follicle antiactive caspase-3 (apoptotic death) and γH2AX (DNA damage) staining intensity significantly increased with transport duration (coefficient: 4.22, 95% CI: 0.26; 8.17 and coefficient: 0.73, 95% CI: 0.26; 1.45, respectively), although primordial follicle density and primordial follicle growth initiation index were not affected. Threshold analyses identified 20.58 and 3.15 hours as critical transport threshold times for apoptotic death and DNA damage. However, DNA damage, as semiquantified by γH2AX staining intensity, was minimal. In addition, stromal hypoxia-inducible factor 1-alpha and AC-3 expressions or stromal cell density did not correlate with transport duration, indicating that hypoxia or stromal damage was not an underlying mechanism of follicular damage.
[CONCLUSION] Extended ovarian tissue transportation does not affect primordial follicle integrity up until 21 hours. The significantly increased primordial follicle apoptosis after 21 hours of transport time does not seem to be due to increased tissue hypoxia, stromal damage, or increased growth activation. Although minimal, increased DNA damage may partially be responsible for transport duration-related apoptotic death of primordial follicles.
[DESIGN] Translational research study.
[SUBJECTS] Whole ovaries (n = 13) or ovarian cortex (n = 3) from 16 individuals (10 deceased organ donors and 6 undergoing clinical ovarian tissue cryopreservation) were transported to our center in appropriate media for cryopreservation. In the clinical group indications were as follows: planned (elective, n = 3), high-grade serous ovarian cancer (n = 1), endometriosis (n = 1), and Hodgkin lymphoma (n = 1).
[EXPOSURE] Transport duration was calculated from cross-clamp time for organ donors, and from the time of oophorectomy or ovarian tissue excision for patients, until ovarian tissue cryopreservation.
[MAIN OUTCOME MEASURES] Antiactive caspase-3, γH2AX, and hypoxia-inducible factor 1-alpha immunostaining were performed to assess follicular and stromal cell apoptosis, oocyte deoxyribonucleic acid (DNA) damage, and tissue hypoxia. Follicle activation was assessed by primordial follicle growth initiation index, defined as the primary/primordial follicle ratio.
[RESULTS] Primordial follicle antiactive caspase-3 (apoptotic death) and γH2AX (DNA damage) staining intensity significantly increased with transport duration (coefficient: 4.22, 95% CI: 0.26; 8.17 and coefficient: 0.73, 95% CI: 0.26; 1.45, respectively), although primordial follicle density and primordial follicle growth initiation index were not affected. Threshold analyses identified 20.58 and 3.15 hours as critical transport threshold times for apoptotic death and DNA damage. However, DNA damage, as semiquantified by γH2AX staining intensity, was minimal. In addition, stromal hypoxia-inducible factor 1-alpha and AC-3 expressions or stromal cell density did not correlate with transport duration, indicating that hypoxia or stromal damage was not an underlying mechanism of follicular damage.
[CONCLUSION] Extended ovarian tissue transportation does not affect primordial follicle integrity up until 21 hours. The significantly increased primordial follicle apoptosis after 21 hours of transport time does not seem to be due to increased tissue hypoxia, stromal damage, or increased growth activation. Although minimal, increased DNA damage may partially be responsible for transport duration-related apoptotic death of primordial follicles.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.